Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Ophthalmic Therapeutics/Drug Revenue
• 1.4 Market by Type
  • 1.4.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Anti-allergy
  • 1.4.3 Anti-VEGF Agents
  • 1.4.4 Anti-inflammatory
  • 1.4.5 Anti-glaucoma
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Ophthalmic Therapeutics/Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Dry Eye
  • 1.5.3 Allergies
  • 1.5.4 Glaucoma
  • 1.5.5 Infection
  • 1.5.6 Retinal Disorders
  • 1.5.7 Uveitis
  • 1.5.8 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Ophthalmic Therapeutics/Drug Market Perspective (2015-2026)
• 2.2 Global Ophthalmic Therapeutics/Drug Growth Trends by Regions
  • 2.2.1 Ophthalmic Therapeutics/Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Ophthalmic Therapeutics/Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Ophthalmic Therapeutics/Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Ophthalmic Therapeutics/Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Ophthalmic Therapeutics/Drug Players by Market Size
  • 3.1.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Ophthalmic Therapeutics/Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio
  • 3.2.1 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutics/Drug Revenue in 2019
• 3.3 Ophthalmic Therapeutics/Drug Key Players Head office and Area Served
• 3.4 Key Players Ophthalmic Therapeutics/Drug Product Solution and Service
• 3.5 Date of Enter into Ophthalmic Therapeutics/Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)
• 5.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Ophthalmic Therapeutics/Drug Market Size (2015-2020)
• 6.2 Ophthalmic Therapeutics/Drug Key Players in North America (2019-2020)
• 6.3 North America Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 6.4 North America Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Ophthalmic Therapeutics/Drug Market Size (2015-2020)
• 7.2 Ophthalmic Therapeutics/Drug Key Players in Europe (2019-2020)
• 7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 7.4 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Ophthalmic Therapeutics/Drug Market Size (2015-2020)
• 8.2 Ophthalmic Therapeutics/Drug Key Players in China (2019-2020)
• 8.3 China Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 8.4 China Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Ophthalmic Therapeutics/Drug Market Size (2015-2020)
• 9.2 Ophthalmic Therapeutics/Drug Key Players in Japan (2019-2020)
• 9.3 Japan Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 9.4 Japan Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Ophthalmic Therapeutics/Drug Market Size (2015-2020)
• 10.2 Ophthalmic Therapeutics/Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Ophthalmic Therapeutics/Drug Market Size (2015-2020)
• 11.2 Ophthalmic Therapeutics/Drug Key Players in India (2019-2020)
• 11.3 India Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 11.4 India Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Ophthalmic Therapeutics/Drug Market Size (2015-2020)
• 12.2 Ophthalmic Therapeutics/Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Alcon
  • 13.1.1 Alcon Company Details
  • 13.1.2 Alcon Business Overview
  • 13.1.3 Alcon Ophthalmic Therapeutics/Drug Introduction
  • 13.1.4 Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020))
  • 13.1.5 Alcon Recent Development
• 13.2 Johnson and Johnson Vision Care, Inc.
  • 13.2.1 Johnson and Johnson Vision Care, Inc. Company Details
  • 13.2.2 Johnson and Johnson Vision Care, Inc. Business Overview
  • 13.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Introduction
  • 13.2.4 Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.2.5 Johnson and Johnson Vision Care, Inc. Recent Development
• 13.3 Bausch & Lomb Incorporated
  • 13.3.1 Bausch & Lomb Incorporated Company Details
  • 13.3.2 Bausch & Lomb Incorporated Business Overview
  • 13.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Introduction
  • 13.3.4 Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.3.5 Bausch & Lomb Incorporated Recent Development
• 13.4 Novartis AG
  • 13.4.1 Novartis AG Company Details
  • 13.4.2 Novartis AG Business Overview
  • 13.4.3 Novartis AG Ophthalmic Therapeutics/Drug Introduction
  • 13.4.4 Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.4.5 Novartis AG Recent Development
• 13.5 Merck Sharp & Dohme Corp.
  • 13.5.1 Merck Sharp & Dohme Corp. Company Details
  • 13.5.2 Merck Sharp & Dohme Corp. Business Overview
  • 13.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Introduction
  • 13.5.4 Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.5.5 Merck Sharp & Dohme Corp. Recent Development
• 13.6 Regeneron Pharmaceuticals Inc.
  • 13.6.1 Regeneron Pharmaceuticals Inc. Company Details
  • 13.6.2 Regeneron Pharmaceuticals Inc. Business Overview
  • 13.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Introduction
  • 13.6.4 Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.6.5 Regeneron Pharmaceuticals Inc. Recent Development
• 13.7 Allergan
  • 13.7.1 Allergan Company Details
  • 13.7.2 Allergan Business Overview
  • 13.7.3 Allergan Ophthalmic Therapeutics/Drug Introduction
  • 13.7.4 Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.7.5 Allergan Recent Development
• 13.8 Pfizer Inc.
  • 13.8.1 Pfizer Inc. Company Details
  • 13.8.2 Pfizer Inc. Business Overview
  • 13.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Introduction
  • 13.8.4 Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.8.5 Pfizer Inc. Recent Development
• 13.9 Valeant
  • 13.9.1 Valeant Company Details
  • 13.9.2 Valeant Business Overview
  • 13.9.3 Valeant Ophthalmic Therapeutics/Drug Introduction
  • 13.9.4 Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.9.5 Valeant Recent Development
• 13.10 Bayer AG
  • 13.10.1 Bayer AG Company Details
  • 13.10.2 Bayer AG Business Overview
  • 13.10.3 Bayer AG Ophthalmic Therapeutics/Drug Introduction
  • 13.10.4 Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 13.10.5 Bayer AG Recent Development
• 13.11 Santen Pharmaceuticals Co. Ltd
  • 10.11.1 Santen Pharmaceuticals Co. Ltd Company Details
  • 10.11.2 Santen Pharmaceuticals Co. Ltd Business Overview
  • 10.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Introduction
  • 10.11.4 Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 10.11.5 Santen Pharmaceuticals Co. Ltd Recent Development
• 13.12 Genentech, Inc.
  • 10.12.1 Genentech, Inc. Company Details
  • 10.12.2 Genentech, Inc. Business Overview
  • 10.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Introduction
  • 10.12.4 Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 10.12.5 Genentech, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer